Drug profile · INN
tetracycline phosphate complex
TETREX
tetracycline phosphate complex (TETREX) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — tetracycline phosphate complex
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tetracycline phosphate complex (TETREX) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tetracycline phosphate complex?
tetracycline phosphate complex (TETREX) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tetracycline phosphate complex?
TETREX is a marketed brand name for tetracycline phosphate complex. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tetracycline phosphate complex?
tetracycline phosphate complex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.